Merck & Co., Inc. (MRK) Stock Chart

NYSE
$147.37+0.00 (+0.00%)After hours

View the Merck & Co., Inc. stock chart with market data, key statistics, volume, financial metrics, latest news, and exportable historical data.

Source
Nasdaq Real Time Price
Quote Time
Oct 14, 2026, 9:19 PM UTC
Delay
20 min source-reported delay

Market data is for research and educational use only, not investment advice. Quotes may be delayed depending on the source and exchange; verify important prices with your broker or data provider.

Read the MRK trend first

Use the range controls to compare short-term moves with the longer-term Merck & Co., Inc. stock chart. A move that looks large on 1D can look routine on a 1Y or 5Y chart.

Check price with volume

Volume helps show whether a move happened with broad participation or thin trading. Compare recent bars with the average volume and news context before drawing conclusions.

Verify before acting

This page is built for research and education. Quotes, analyst fields, and news can be delayed or revised, so verify important prices with your broker or primary data provider.

Key Statistics

Previous Close$141.98
Open$143.10
Day Range$142.66 — $148.13
52 Wk Range$82.01 — $156.92
Volume9,784,632
Avg Volume9,825,946
Market Cap363.59B
P/E (TTM)116.96
P/E (Fwd)15.87
EPS (TTM)$1.26
Dividend Yield2.39%
Beta0.22
50 Day Avg$144.05
200 Day Avg$124.28
Shares Out2.47B
PEG Ratio2.65
Price/Book8.68

Financial Metrics

Revenue
66.57B
Revenue Growth
5.10%
Gross Margin
75.90%
Operating Margin
-0.24%
Profit Margin
4.77%
Return on Equity
6.96%
Total Cash
7.14B
Total Debt
53.91B
Free Cash Flow
15.17B
Analyst Target
$158.64
Analyst Consensus
Buy
Analyst Opinions
25

About Merck & Company, Inc.

Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
73,000
Headquarters
Rahway, NJ, United States
Website
merck.com
CEO
Mr. Robert M. Davis J.D.

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Related Charts

Data Definitions

Previous close

The most recent prior regular-session close reported by the market data source.

Day range

The source-reported high and low for the current or most recent trading session.

Volume

The number of shares, units, contracts, or asset quantity reported as traded during the period.

Moving averages

The 50-day and 200-day averages smooth recent prices to give quick trend context.

Market cap

A company or fund size estimate based on price and shares outstanding when source data is available.

P/E ratio

Price divided by earnings per share. It is most useful when compared with peers and growth expectations.